Jonah Comstock

October 8, 2018
Mira, the women’s health startup that launched last month at TechCrunch disrupt and won a recent startup competition at Health 2.0, has moved fast. The three-year old company has 36 employees, a device nearly on the market, and FDA and CE Mark clearances. And almost unheard of for a tech startup, it does its own manufacturing. “We built 11,000 square feet of manufacturing facility ourselves,...
October 5, 2018
The third quarter of 2018 was a surprisingly good one for mergers and acquisitions. Babyforyou.net.ua tracked 17 deals, from Best Buy’s monster acquisition of GreatCall, to positive exits for Boston area startups Herald Health and Circulation, to WebMD’s snapping up consumer healthcare reviews site Vitals. The majority of the deals seem to represent the kind of consolidation that happens as a space...
October 4, 2018
Editor's note: A previous version of this article said that the Aysa app would be sold with a $1.99 annual subscription. This has been corrected to $9.99.  Clinical decision support tool maker VisualDx officially launched Aysa, its first consumer-facing app, last month at Health 2.0 in San Francisco. The app allows users to upload pictures of skin lesions or rashes, enter some additional...
October 2, 2018
American consumers are more often using online review sites to choose doctors, and they’re increasingly trusting of those reviews, especially millennials, according to a new survey of 1,000 US adults. The survey, conducted by One Poll and sponsored by digital-focused healthcare marketing company Binary Fountain, found that 95 percent of respondents — and 97 percent of millennials — found online...
October 2, 2018
Researchably, a young startup incubated at UC Berkeley, is conducting a pilot with Sanofi in China, using AI to sift through thousands of research studies and surface the most relevant ones to pharma stakeholders. “With Sanofi we’re working with a small medical communications team, and they’re in charge of every day reviewing 100 to 200 articles on Type 2 diabetes to then inform business units...

The Freestyle Libre 1.

October 1, 2018
Abbott has received CE Mark clearance for the second generation of its Freestyle Libre device, which will allow the company to make the device available to users in Europe. It will be rolled out gradually in Europe starting in the next few weeks, and it will be offered as the same price as the first generation device. Freestyle Libre 1, which has been available in Europe since 2014, is a fully...
finish line on track
September 28, 2018
For a digital health startup looking to be deployed in a hospital, it can seem like finally landing that big hospital pilot is the culmination of months or years of effort. But hospitals and startups alike quickly learn that it’s just the beginning of a difficult process, and that many pilots die without being turned into full scale deployments. “I think this pilot cemetery or death by pilot...
September 27, 2018
What happened Butterfly Health Network has raised $250 million in new funds and will soon begin shipping its sub-$2,000, handheld, tablet-connected full-body ultrasound device, Butterfly IQ. Fidelity led the investment, with additional participation from Fosun Pharma, Bill & Melinda Gates Foundation, and Jamie Dinan, along with existing investors. The round brings the company’s total funding...

Meg Barron, center, speaks on a panel on innovation at Health 2.0's Provider Symposium last week.

September 26, 2018
The American Medical Association has moved past merely calling out “digital health snake oil.” Over the last few years, the organization has dedicated a lot of resources to fostering positive digital health innovation — and making sure that innovation is physician-led whenever possible. “If there’s over 300,000 [digital health] apps and solutions, and over 40,000 that are directly patient-facing...

Ascensia's Contour Next was the top-performing meter in the study.

September 26, 2018
What happened In a triple-blinded, multisite, independent study, researchers have found that only one third of commercially available FDA-cleared blood glucose meters in the United States could consistently perform to an accuracy standard close to, but actually more lenient than, the FDA’s. Of the 18 BCGs tested, only six were consistently accurate in each of three test sites. Five were compliant...